Skip to main content

Table 1 Patient characteristics

From: Proteomic characteristics and diagnostic potential of exhaled breath particles in patients with COVID-19

Characteristics

COV-POS

COV-NEG

HCO

Number of participants

20

16

12

Sex: Male

10 (50%)

8 (50%)

4 (44%)

Age (Median)

56 (IQR: 53–64)

69 (IQR: (53–80)

44 (IQR: 29–46)

Days since symptom debut*

8 (IQR: 3.75–10)

2 (IQR: 1–4.75)

0

Clinical diagnosis

 Infectious etiology

  Viral

20 (100%)

5 (31.3%)

0 (0%)

  Bacterial

0 (0%)

4 (25%)

0 (0%)

  Unknown

0 (0%)

5 (31,3%)

0 (0%)

  Non-infectious respiratory symptoms

0 (0%)

2 (12.5%)

0 (0%)

 Comorbidities

  Asthma

1 (5%)

0 (0%)

0 (0%)

  COPD

3 (15%)

1 (6.25%)

0 (0%)

  Obesity

10 (50%)

4 (25%)

1 (8.3%)

 Symptoms

   

  Coughing

14 (70%)

8 (50%)

0 (0%)

  Fever

11 (55%)

6 (38%)

0 (0%)

  Throat pain

2 (10%)

3 (19%)

0 (0%)

  Stomach pain

4 (20%)

4 (25%)

0 (0%)

  Dyspnea

19 (95%)

9 (56%)

0 (0%)

  Myalgia

3 (15%)

1 (6%)

0 (0%)

  Hospitalized

20 (100%)

7 (44%)

0 (0%)

  1. Characteristics for patients with PCR-verified COVID-19 infection (COV-POS), COVID-19 PCR-negative patients with respiratory symptoms (COV-NEG) and healthy controls (HCO)
  2. IQR Interquartile range
  3. *Or days since seeking medical care if unknown. Descriptive statistics presented as number of patients and percentage